Friday, April 26, 2024

Friday, April 26, 2024

Organization Directory

Refine Your Search A

Type:

Filter by Org Type:

Filter By Name:


Trending

  1. 1 ASTELLAS PHARMA INC.: FDA Accepts for Priority Review the New Drug Application for mirabegron for Oral Suspension and Supplemental New Drug Application for Myrbetriq® (mirabegron) Tablets in Pediatric Patients
  2. 2 FUNCTIONAL NEUROMODULATION: Announces Breakthrough Device Designation from the U.S. FDA for Deep Brain Stimulation for Alzheimer's Disease
FDA Reporter